We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2004 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00173316
First Posted: September 15, 2005
Last Update Posted: December 9, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Taiwan University Hospital
  Purpose
The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Condition
Oral Cancer

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Retrospective
Official Title: The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 80
Study Start Date: August 2004
Estimated Study Completion Date: June 2005
Detailed Description:
The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • oral cancer and oral precancer specimens

Exclusion Criteria:

  • other diseases
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00173316


Contacts
Contact: Chun-Pin Chiang, DMSc 886-2-23123456 ext 6855 cpchiang@ha.mc.ntu.edu.tw

Locations
Taiwan
National Taiwan university Recruiting
Taipei, Taiwan, 100
Principal Investigator: Chun-Pin Chiang, DMSc         
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Chun-Pin Chiang, DMSc National Taiwan University
  More Information

ClinicalTrials.gov Identifier: NCT00173316     History of Changes
Other Study ID Numbers: 9461700614
First Submitted: September 12, 2005
First Posted: September 15, 2005
Last Update Posted: December 9, 2005
Last Verified: August 2004

Keywords provided by National Taiwan University Hospital:
vascular endothelial growth factor-C
VEGF-CR
lymphangiogenesis
host inflammatory responses
oral carcinogenesis
oral cancers
oral premalignant lesions

Additional relevant MeSH terms:
Mouth Neoplasms
Lip Neoplasms
Precancerous Conditions
Carcinogenesis
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms
Mouth Diseases
Stomatognathic Diseases
Lip Diseases
Neoplastic Processes
Pathologic Processes
Endothelial Growth Factors
Growth Substances
Physiological Effects of Drugs